USA

News

FDA Approves Lipiodol® (Ethiodized Oil) Injection for Imaging of Tumors in Adults with Known HCC

10.04.2014 12:00

Guerbet LLC, USA (April 10, 2014)

Princeton (NJ), Guerbet, a pioneer in the field of contrast agents for medical imaging announced that Lipiodol® was approved by the US Food and Drug Administration pursuant to section 505(b)(2) of he Federal Food, Drug, and Cosmetic Act indicated for selective hepatic intra-arterial use for imaging tumors in adults with known hepatocellular carcinoma (HCC).

 Read the press release